Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/13/2025

GLP-1 Analogues Guidance

Introduction to GLP-1 Analogues

  • The American College of Cardiology associated journal recommends that taking GLP-1 analogues without prior laboratory testing is not advised as it may lead to unrecognized adverse effects, particularly in patients with undiagnosed diabetes, renal impairment, or other metabolic disorders that could impact drug safety and efficacy 1
  • The use of GLP-1 analogues can lead to hypoglycemia risk, particularly if combined with insulin secretagogues or insulin without proper dose adjustment, as noted by Diabetes Care 2
  • Undiagnosed renal impairment is a concern with GLP-1 analogues, as several require dose adjustment or are contraindicated in severe renal impairment, according to Anaesthesia 1

Patient Selection and Monitoring

  • Patients with pre-existing gastroparesis may experience delayed gastric emptying with GLP-1 analogues, which can be problematic, as indicated by Anaesthesia 1
  • There is an increased risk of pulmonary aspiration, particularly concerning for patients who might need emergency surgery, as reported by Anaesthesia 1
  • The American College of Cardiology associated guidelines suggest that long-acting vs. short-acting GLP-1 analogues have different pharmacokinetic profiles that affect gastric emptying differently 1
  • Semaglutide is associated with an increased risk of diabetic retinopathy complications in patients with pre-existing retinopathy, according to the Journal of the American College of Cardiology 3
  • Tirzepatide, as a dual GIP/GLP-1 receptor agonist, may have a different risk profile than pure GLP-1 analogues, as noted by Anaesthesia 1

Perioperative Management

  • GLP-1 analogues delay gastric emptying, increasing the risk of aspiration during anesthesia, as reported by Anaesthesia 4
  • Recommendations for surgery include continuing GLP-1 analogues throughout the perioperative period but implementing aspiration risk reduction strategies, according to Anaesthesia 1

Dosing and Administration

  • Diabetes Care recommends starting at a gradual dose to minimize gastrointestinal side effects, rather than starting at full dose 2
  • It is crucial to educate patients about hypoglycemia symptoms and management, expected gastrointestinal side effects, and the need for adequate hydration, as generally recommended by medical guidelines 2